rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGGCTCGCACCCAGGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASRLAPRSE*KTYGYTF	Stop	VDJ	1	24	8.176057777474961E-4		54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	4	9	14	23	34	47	43	61			01,02										Vb 1	CASRLAPRSE*KTYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGACAGGGGCAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	7.494719629352047E-4		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	2	4	2	4	29	43	53	45	57													Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGTGGCTACGAGCAGTACTTCGGGCCG	CASSQGGYEQYF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	3	0	3	29	-1	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACTTTGGGGGGGCATCTGGCTACACCTTCGGTTCG	CASSQDFGGASGYTF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	7	4	4	29	46	57	50	61													Vb 16	CASSQDFGGASGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCTCGGGACAGGGCCAATTCGGGCCG		Out	VDJ	1	45	0.0015330108332765552		34	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	16	5	4	29	42	56	47	60													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACCCCGCGACGGAGCCAGGGAGATATGCAGTATTTTGGCCCA	CASSQTPRRSQGDMQYF	In	VDJ	1	46	0.0015670777406827008	0.0021468241004340316	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	2	4	3	11	15	6	29	44	64	59	70				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQTPRRSQGDMQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACTTCGCCGTGAACACTGAAGCTTTCTTTGGACAA	CASSQDFAVNTEAFF	In	VDJ	2	122	0.004156162703549772	0.005693750875064171	45	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	10	0	0	4	2	29	46	52	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDFAVNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGCGAGCAGGGGGCCCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	54	3454	0.11766709818082714		53	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	0	2	7	1	28	45	60	52	61													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATTTGGTCAAACAGATACGCAGTATTTTGGCCCA	CASSVFGQTDTQYF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	0	10	3	6	4	24	36	44	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVFGQTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTACAGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSTGANTEAFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	1	1	1	24	35	43	36	44														CASSTGANTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAAGGGGACAGGGTTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	20	6.813381481229134E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	1	5	1	24	35	49	40	50														X+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCGAGGGGACACCAGCCACTGAAGCTTTCTTTGGACAA	CASSVEGTPATEAFF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	4	6	5	24	36	48	42	53														CASSVEGTPATEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACAGGTCGGGGGACATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	7.835388703413504E-4		47	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	2	0	6	1	8	0	24	39	-1	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCAGGGGCGGTAGATACGCAGTATTTTGGCCCA	CASSVSGAVDTQYF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	5	4	4	24	36	46	40	50														CASSVSGAVDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTCAGGACTAGCGGGGGTTTATCAGTTCTTCGGGCCA	CASSSGLAGVYQFF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	1	2	13	4	5	24	35	52	39	57														CASSSGLAGVYQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGGCAGGAAACTATGGCTACACCTTCGGTTCG	CASSVAGNYGYTF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	2	4	1	24	36	44	40	45														CASSVAGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGTTTACCGAGACTAAAAATGAGCAGTTCTTCGGGCCA	CASRFTETKNEQFF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	9	7	9	2	24	35	49	44	51						01,02								CASRFTETKNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAGACAGGGGCCAGAACCGGGGAGCTGTTTTTTGGAGAA	CASSQTGARTGELFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	5	2	5	24	36	46	38	51														CASSQTGARTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGTCAGCAGCGGTAGCGGGGGGGCGAATGAGCAGTTCTTCGGGCCA	CVSSGSGGANEQFF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	7	2	2	24	36	49	38	51														CVSSGSGGANEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATGGGGACAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLWGQSSGANVLTF	In	VDJ	1	40	0.0013626762962458269	0.0018668035655948103	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	5	0	5	2	24	36	48	41	50														CASSLWGQSSGANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTTATTCTAAGAACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFILRTGGNQPQHF	In	VDJ	1	41	0.0013967432036519724	0.0019134736547346805	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	2	13	0	24	35	-1	48	55														CASSFILRTGGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGAGGAGGCGATACGCAGTATTTTGGCCCA	CASSRGGDTQYF	In	VDJ	1	44	0.0014989439258704094	0.0020534839221542913	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	1	6	4	1	24	35	44	39	45														CASSRGGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTAACACCCTAGCGGGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSNTLAGVADTQYF	In	VDJ	1	56	0.0019077468147441574	0.0026135249918327343	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	4	7	3	24	35	52	42	55														CASSNTLAGVADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGCCGCCAGGGAAAGGACAGATACGCAGTATTTTGGCCCA	CASAARERTDTQYF	In	VDJ	2	109	0.003713292907269878	0.005087039716245858	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	4	3	3	7	5	24	31	43	38	48														CASAARERTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAGTTTACCTAAATAGATATGGCTACACCTTCGGTTCG	CASSEVYLNRYGYTF	In	VDJ	3	176	0.005995775703481638	0.008213935688617165	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	4	9	5	10	6	24	35	48	45	54						01,02								CASSEVYLNRYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAAAAGGGAGGACAGGGGGAAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	4	252	0.008584860666348709		53	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	1	5	4	24	39	54	44	58														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTTCCTCCTGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSWSSYNEQFF	In	VDJ	5	334	0.011378347073652654	0.015587809772716666	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	10	2	0	9	0	24	31	-1	40	44														CASSSWSSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGTDTQYF	In	VDJ	18	1146	0.039040675887442935	0.05348392215429131	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	1	1	3	24	36	40	37	43						01,02								CASSLVGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCCTGTATCTCTGTGCCAGCAGCCGTCGCCATAGGGGTATTGGGGACGGAGGGTATGTGGGGGAGCTGTTTTTTGGAGAA	CASSRRHRGIGDGGYVGELFF	In	VDJ	1	33	0.0011242079444028072	0.0015401129416157185	63	TCRBV04	TCRBV04-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	0	8	23	6	18	31	60	54	66														CASSRRHRGIGDGGYVGELFF+TCRBV04-02+TCRBJ02-02	TCRBV04-02*01	TCRBD02-01*02	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTATATGGGGGCTCCACTGAAGCTTTCTTTGGACAA	CASSLVYGGSTEAFF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	6	0	4	7	2	18	32	45	39	47														CASSLVYGGSTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTCGGGGAGATTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSFRGDLAKNIQYF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	8	3	0	1	6	19	33	39	34	45						01,02								CASSFRGDLAKNIQYF+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01	TCRBD02-01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCCTTTATCTTTGCCAGCGAAGTTTCCAATAGTCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	26	8.857395925597874E-4		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	13	6	6	5	1	22	19	22	27	23	49						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGTCTGGTAGTGACTGAAGCTTTCTTTGGACAA	CASSLGGLVVTEAFF	In	VDJ	1	31	0.0010560741295905158	0.001446772763335978	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	1	5	0	10	19	-1	39	35	49													Vb 5.1	CASSLGGLVVTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGAATAATAACAATGAGCAGTTCTTCGGGCCA	CASSFGNNNNEQFF	In	VDJ	4	260	0.008857395925597875	0.012134223176366267	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	2	0	8	5	1	6	19	33	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFGNNNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCTAAGGAATTATTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	54	0.0018396129999318663		50	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	5	22	31	47	43	52														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGGGGACGGATCCTACGAGCAGTACTTCGGGCCG	CASSPGDGSYEQYF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	1	1	5	25	37	44	38	49													Vb 3	CASSPGDGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGGCGCAAACCATGGCTACACCTTCGGTTCG	CASRGGANHGYTF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	6	0	6	1	7	25	36	43	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRGGANHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGTCGCCTCAGGGGTTCGGGCCCCTATCTCCTACGAGCAGTACTTCGGGCCG	CASVASGVRAPISYEQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	2	0	7	13	25	34	47	41	60													Vb 3	CASVASGVRAPISYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCTACGTTTACAGGGGAAAGCTTTCTTTGGACAA	CASTLRLQGKAFF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	9	10	1	25	35	52	45	53													Vb 3	CASTLRLQGKAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGCATAGGACAGGGGCGAGATGGCTACACCTTCGGTTCG	CASSGIGQGRDGYTF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	6	6	4	25	37	52	43	56													Vb 3	CASSGIGQGRDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTGTCGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLSGTDTQYF	In	VDJ	1	24	8.176057777474961E-4	0.0011200821393568862	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	5	1	5	0	25	39	-1	44	47						01,02							Vb 3	CASSFLSGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACAGGGGTTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGVGTGELFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	2	4	0	4	25	-1	47	40	51													Vb 3	CASSLTGVGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGAAGATCGAACACTGAAGCTTTCTTTGGACAA	CASGRSNTEAFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	1	8	1	0	5	25	-1	37	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGRSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGGACCGTTAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	0.0010560741295905158		41	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	8	0	7	0	1	6	25	34	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCTGGAATGAACACTGAAGCTTTCTTTGGACAA	CASSFAGMNTEAFF	In	VDJ	1	33	0.0011242079444028072	0.0015401129416157185	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	3	1	8	0	4	1	25	39	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFAGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATGGTGGTCGGACACAGGGGGCTACACCTTCGGTTCG	CASRWWSDTGGYTF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	8	13	0	25	36	-1	49	55													Vb 3	CASRWWSDTGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGTCTTCAGGGAATTCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	38	0.0012945424814335355		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	5	6	6	25	40	51	46	57													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTACTAGCGGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	0.0014648770184642638		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	3	3	8	1	0	25	41	-1	42	52													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGGACGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSSPDGASYEQYF	In	VDJ	1	44	0.0014989439258704094	0.0020534839221542913	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	4	7	0	0	8	0	25	38	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSPDGASYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGGGGACAGTAGTTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	0.0016352115554949921		46	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	4	7	25	37	48	41	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCTAAAAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	0.001771479185119575		37	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	5	5	3	5	6	0	25	37	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCTGGTAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASTPGRVNTEAFF	In	VDJ	1	75	0.0025550180554609254	0.0035002566854902693	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	5	3	0	8	0	25	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPGRVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAGGGCGGACACTGAAGCTTTCTTTGGACAA	CASSWDRADTEAFF	In	VDJ	1	81	0.0027594194998977993	0.0037802772203294906	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	0	3	25	-1	47	38	50													Vb 3	CASSWDRADTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTACCGTTCCGACAGTAGGGAGGTTGGGAGATACGCAGTATTTTGGCCCA	CASSPTVPTVGRLGDTQYF	In	VDJ	1	88	0.002997887851740819	0.004106967844308583	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	1	5	18	5	24	36	60	54	65													Vb 3	CASSPTVPTVGRLGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGGGAATAGCGGGGGACCGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRE*RGTAGTGELFF	Stop	VDJ	1	23	7.835388703413504E-4		51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	5	2	4	4	8	18	29	42	33	50														CASRE*RGTAGTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCATTCGGCCGCCTCCACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	45	0.0015330108332765552		56	TCRBV12	TCRBV12-02	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	14	7	18	30	47	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01		TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSEGDSSYEQYF	In	VDJ	2	106	0.003611092185051441	0.004947029448826247	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	0	0	0	23	-1	-1	39	46														CASSEGDSSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAGGAGGAGCGGGGTACTACGAGCAGTACTTCGGGCCG	CASSEGGGAGYYEQYF	In	VDJ	4	268	0.00912993118484704	0.01250758388948523	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	3	3	7	2	23	39	53	46	55														CASSEGGGAGYYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAAAAAGGGGGCATTGTGGTCGATGAGCAGTTCTTCGGGCCA	CAWSEKGGIVVDEQFF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	8	6	10	26	37	50	43	60													Vb 20	CAWSEKGGIVVDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACAGGAAACAATCAGCCCCAGCATTTTGGTGAT	CAWSTGNNQPQHF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	4	3	0	3	26	-1	43	38	46													Vb 20	CAWSTGNNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGGAACAATCAGCCCCAGCATTTTGGTGAT	CAWSVGNNQPQHF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	0	0	8	3	1	1	26	40	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGNNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCCGGGACAGGGATTGTTATCTATGGCTACACCTTCGGTTCG	CAWSGTGIVIYGYTF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	4	3	8	26	35	47	38	55													Vb 20	CAWSGTGIVIYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTGATAGCAGAGTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	28	9.538734073720787E-4		53	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	5	7	5	3	17	26	35	42	38	59			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD02-01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACAGGGTACGGGGCACAGATACGCAGTATTTTGGCCCA	CAWSYRVRGTDTQYF	In	VDJ	1	36	0.0012264086666212441	0.0016801232090353294	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	3	1	1	6	26	38	45	39	51													Vb 20	CAWSYRVRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCTTACGGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	40	0.0013626762962458269		37	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	2	6	6	0	26	37	-1	43	49			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCCTCACAGGGGTCGATCAGCCCCAGCATTTTGGTGAT	CAWALTGVDQPQHF	In	VDJ	1	45	0.0015330108332765552	0.0021001540112941617	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	5	6	3	26	35	48	41	51			unresolved										Vb 20	CAWALTGVDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCAAGAATAGTGTAGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	57	0.0019418137221503032		47	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	2	5	4	4	14	0	26	38	-1	52	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCCGGGGGTGAGACCCAGTACTTCGGGCCA	CAWSVPGGETQYF	In	VDJ	1	67	0.00228248279621176	0.0031268959723713074	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	2	5	3	1	26	40	49	43	50			unresolved										Vb 20	CAWSVPGGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGCCCAGGGGCGCCCGGAAACACCATATATTTTGGAGAG	CAWRSPGAPGNTIYF	In	VDJ	1	82	0.002793486407303945	0.003826947309469361	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	2	4	5	5	26	37	48	42	53													Vb 20	CAWRSPGAPGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCGTGAACACTGAAGCTTTCTTTGGACAA	CAWIVNTEAFF	In	VDJ	1	83	0.0028275533147100905	0.0038736173986092313	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	6	0	1	0	26	36	-1	37	39			unresolved			01,02							Vb 20	CAWIVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCTACTAAACACTGAAGCTTTCTTTGGACAA	CAWLLNTEAFF	In	VDJ	2	112	0.003815493629488315	0.005227049983665469	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	9	2	2	0	26	35	-1	37	41			unresolved			01,02							Vb 20	CAWLLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTTACTGATGAAAAACTGTTTTTTGGCAGT	CAWSLTDEKLFF	In	VDJ	2	113	0.003849560536894461	0.005273720072805339	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	3	10	6	4	1	26	37	44	41	45			unresolved			01,02							Vb 20	CAWSLTDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCGGGCCTCAGTGGAGAGTAGATAATTCACCCCTTCACTTTGGGAAC	CASGPQWRVDNSPLHF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	48	TCRBV27	TCRBV27-01	01				TCRBJ01	TCRBJ01-06	01	8	8	0	19	0	29	23	-1	36	32	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASGPQWRVDNSPLHF+TCRBV27-01+TCRBJ01-06	TCRBV27-01*01		TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACTAGCGGAGCTTCCAATGAGCAGTTCTTCGGGCCA	CSVEGTSGASNEQFF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	5	6	0	6	25	-1	48	38	54						01,02							Vb 4	CSVEGTSGASNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGGGACGGATCCTACGAGCAGTACTTCGGGCCG	CSGGDGSYEQYF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	9	1	1	0	5	25	-1	38	32	43													Vb 4	CSGGDGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGCGCCGGGGAGCGGAGACCCAGTACTTCGGGCCA	CSGRRGAETQYF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	8	3	5	5	4	25	32	42	37	46						01,02							Vb 4	CSGRRGAETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCCTGGGGTCCCCCTGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	8.516726851536418E-4		47	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	6	2	0	5	8	25	33	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTTCTGGGTTCCTACGAGCAGTACTTCGGGCCG	CSVEFLGSYEQYF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	2	0	9	1	5	1	25	37	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEFLGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCGGCGGGCACAGATACGCAGTATTTTGGCCCA	CSVSAGTDTQYF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	1	3	0	25	34	-1	37	41						01,02							Vb 4	CSVSAGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTATGTGATTACAGGGGGCTGTTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	29	9.879403147782244E-4		52	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	0	1	9	3	25	35	53	44	56													Vb 4	X+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCCACGGGGGGTGTGGGTGAAAAACTGTTTTTTGGCAGT	CSVAPTGGVGEKLFF	In	VDJ	1	33	0.0011242079444028072	0.0015401129416157185	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	8	1	7	6	6	25	35	48	41	54													Vb 4	CSVAPTGGVGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCACCTCTGGAAACACCATATATTTTGGAGAG	CSVATSGNTIYF	In	VDJ	1	42	0.0014308101110581182	0.0019601437438745506	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	4	3	7	0	2	0	25	35	-1	37	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVATSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCCCGGCCAGAAGCACTGAAGCTTTCTTTGGACAA	CSVEPPARSTEAFF	In	VDJ	2	110	0.0037473598146760237	0.005133709805385728	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	2	4	5	4	8	3	25	37	48	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEPPARSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGTCAAGGCTAGCATTTTCTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	147	0.005007835388703414		49	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	7	4	9	7	25	35	49	44	56						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCGTGGGGACAGGGGGCCTGTGGGCTGAAGCTTTCTTTGGACAA	CSGVGTGGLWAEAFF	In	VDJ	4	247	0.00841452612931798	0.011527512017547953	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	0	6	5	7	25	32	49	37	56													Vb 4	CSGVGTGGLWAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACAACTTTGACAGGGACACCTACGAGCAGTACTTCGGGCCG	CASSHNFDRDTYEQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	2	7	3	23	37	51	44	54														CASSHNFDRDTYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGCTAGCGGCCCAGATACGCAGTATTTTGGCCCA	CASSQEASGPDTQYF	In	VDJ	1	30	0.0010220072221843702	0.0014001026741961077	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	5	4	2	2	23	40	49	42	51						01,02								CASSQEASGPDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCGATGGGTGTTTGTGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSDGCLCRANVLTF	In	VDJ	1	76	0.002589084962867071	0.0035469267746301397	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	5	0	9	5	3	10	23	35	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSDGCLCRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCTACGTCGGGTAGCGGGGCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	49	0.0016692784629011377		46	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	5	3	3	9	2	22	31	48	40	50														X+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTACGGACTGATACGTGGGGCACCATATATTTTGGAGAG	CASSLRTDTWGTIYF	In	VDJ	1	30	0.0010220072221843702	0.0014001026741961077	45	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	1	10	9	1	11	20	35	41	36	52			01,02			01,02								CASSLRTDTWGTIYF+TCRBV07-08+TCRBJ01-03	TCRBV07-08	TCRBD02-01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGGACAGGGTCAACCTACGAGCAGTACTTCGGGCCG	CASSWTGSTYEQYF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	1	4	23	35	44	36	48													Vb 12	CASSWTGSTYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAATCCGACAGGGGGACGGATCAGCCCCAGCATTTTGGTGAT	CASSESDRGTDQPQHF	In	VDJ	1	24	8.176057777474961E-4	0.0011200821393568862	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	1	5	4	4	23	37	50	41	54													Vb 12	CASSESDRGTDQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCGTGAGAACTCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	8.516726851536418E-4		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	10	0	7	1	23	38	48	45	49						01,02							Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACGGACGGGTTGACACAGATACGCAGTATTTTGGCCCA	CASSDGRVDTDTQYF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	3	1	7	2	1	7	23	37	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDGRVDTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTATGACAGGGGAAGTCGCGCGGCAGTACTTCGGGCCG	CASSMTGEVARQYF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	9	2	10	23	35	45	37	55													Vb 12	CASSMTGEVARQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGTCACGGGGGGACCGGGGAGACCCAGTACTTCGGGCCA	CASSGHGGTGETQYF	In	VDJ	1	42	0.0014308101110581182	0.0019601437438745506	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	5	4	6	23	36	47	40	53													Vb 12	CASSGHGGTGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGTACTCATCTCCAGGACAACGAGCAGTTCTTCGGGCCA	CASRTHLQDNEQFF	In	VDJ	4	227	0.007733187981195067	0.01059411023475055	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	6	10	14	2	23	32	51	46	53													Vb 12	CASRTHLQDNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTAAAGGGGGAAAGGTAGGTTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	23	7.835388703413504E-4		52	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	1	4	2	12	23	39	47	41	59													Vb 12	X+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTATTCTTGCGACAGGGGGAACCACTAACTATGGCTACACCTTCGGTTCG	CAISESILATGGTTNYGYTF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	60	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	1	0	9	5	21	38	56	47	61													Vb 12	CAISESILATGGTTNYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCACTGGTACAGGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CATGTGDSNQPQHF	In	VDJ	1	48	0.0016352115554949921	0.0022401642787137723	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	3	2	1	5	2	24	31	43	36	45													Vb 12	CATGTGDSNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGAAATGGCAAATCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	20	6.813381481229134E-4		56	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	25	37	56	53	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACCCGGGACAGGGGAGCCCAGTACTTCGGGCCA	CASSITRDRGAQYF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	9	5	2	27	41	56	46	58			01,02										Vb 17	CASSITRDRGAQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIVFSGANVLTF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	4	10	0	3	1	27	41	46	44	47			01,02			01,02							Vb 17	CASSIVFSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGAGGGGTGGGGGGACCAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	0.0010560741295905158		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	9	1	5	8	5	27	37	51	45	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGGGTCTCAGCCCCAGCATTTTGGTGAT	CASSIEGSQPQHF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	0	5	3	6	0	2	27	-1	48	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAACCTGATGGGAACGCAGTATTTTGGCCCA	CASSINLMGTQYF	In	VDJ	1	36	0.0012264086666212441	0.0016801232090353294	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	0	8	9	9	0	27	41	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSINLMGTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGTAGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASNVGYSNQPQHF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	5	3	0	4	2	27	37	45	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNVGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTGGGACGAGCGGAGGCTACACCTTCGGTTCG	CASSFGTSGGYTF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	0	7	8	3	7	27	39	47	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFGTSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCTTTCTACGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPFLRGNTGELFF	In	VDJ	1	45	0.0015330108332765552	0.0021001540112941617	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	3	1	10	0	27	38	-1	48	53			01,02										Vb 17	CASSPFLRGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGGTGACCAGCCCCAGCATTTTGGTGAT	CASSIRGDQPQHF	In	VDJ	1	47	0.0016011446480888466	0.002193494189573902	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	2	7	1	4	27	41	47	42	51			01,02										Vb 17	CASSIRGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGACTAGCAGGAATTCACGAGCAGTACTTCGGGCCG	CASSPRLAGIHEQYF	In	VDJ	1	48	0.0016352115554949921	0.0022401642787137723	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	7	5	4	8	27	39	50	43	58			01,02			01,02							Vb 17	CASSPRLAGIHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGGAGGGTATAGGGGAGCAGTACTTCGGGCCG	CASSISEGIGEQYF	In	VDJ	1	52	0.001771479185119575	0.0024268446352732533	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	7	3	7	27	41	50	44	57			01,02										Vb 17	CASSISEGIGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTATACCGACAGAACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	0.0018736799073380119		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	2	8	3	27	38	51	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATCAAACAGGGAGGGGACAGCCCCAGCATTTTGGTGAT	CASSYQTGRGQPQHF	In	VDJ	1	63	0.002146215166587177	0.0029402156158118264	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	0	7	9	2	27	39	55	48	57			01,02										Vb 17	CASSYQTGRGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAATGCCAGGGGTTGGGAGACCCAGTACTTCGGGCCA	CASSMNARGWETQYF	In	VDJ	1	75	0.0025550180554609254	0.0035002566854902693	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	2	5	6	4	27	41	53	47	57			01,02										Vb 17	CASSMNARGWETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGCAGGGCCTAAGAGAGCAGTACTTCGGGCCG	CASSQQGLREQYF	In	VDJ	1	76	0.002589084962867071	0.0035469267746301397	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	7	3	7	27	39	47	42	54			01,02										Vb 17	CASSQQGLREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGGACTAGCGGGGCCCAGTATTTCGGGCCA	CASSAGTSGAQYF	In	VDJ	1	77	0.0026231518702732166	0.0035935968637700096	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02			5	0	3	19	3	8	27	39	55	42	63			01,02					TCRBJ02-01,TCRBJ02-05					Vb 17	CASSAGTSGAQYF+TCRBV19-01+TCRBJ02-X	TCRBV19-01	TCRBD02-01*01	TCRBJ02	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSSGGETQYF	In	VDJ	1	78	0.002657218777679362	0.00364026695290988	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	4	1	0	27	39	-1	40	47			01,02										Vb 17	CASSSGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCGGGACATCGAGGGGGGAGCTATTTTTTGGAGAA	CASRTGTSRGELFF	In	VDJ	1	81	0.0027594194998977993	0.0037802772203294906	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	6	0	6	17	4	15	27	38	48	42	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTGTSRGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACATCCGGGGAGCTGTTTTTTGGAGAA	CASSIGTSGELFF	In	VDJ	1	86	0.0029297540369285276	0.004013627666028842	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	6	6	0	1	27	-1	48	43	49			01,02										Vb 17	CASSIGTSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGCCAGCTAACTATGGCTACACCTTCGGTTCG	CASSMGPANYGYTF	In	VDJ	1	89	0.003031954759146965	0.004153637933448453	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	7	0	0	0	3	27	-1	46	41	49			01,02										Vb 17	CASSMGPANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGAGCCGCGCCCAGCCAAAAACATTCAGTACTTCGGCGCC	CASEPRPAKNIQYF	In	VDJ	5	313	0.010662942018123595	0.014607737900779391	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	9	6	7	0	2	7	27	35	40	37	47			01,02			01,02							Vb 17	CASEPRPAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTGGGGTTGGGGTCGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	38	0.0012945424814335355		53	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-02	01	2	6	2	1	2	10	23	38	44	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTAGGATTTGAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	41	0.0013967432036519724		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTGCAGCCGCACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	YASSAAARQSRANVLTF	In	VDJ	1	55	0.0018736799073380119	0.002566854902692864	51	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	10	5	27	39	53	49	58														YASSAAARQSRANVLTF+TCRBV26-01+TCRBJ02-06	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCCCTAGCGGGGATAAATGAGCAGTTCTTCGGGCCA	CASSPLAGINEQFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	7	3	3	19	31	43	34	46		TCRBV11-01,TCRBV11-03												CASSPLAGINEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGGTGGCGGGGGGAAAACTGTTTTTTGGCAGT	CASSYGVAGGKLFF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	1	10	9	0	28	40	-1	49	57		TCRBV06-04,TCRBV06-08												CASSYGVAGGKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAATAGACAGGGGGCAGCATAAGGTGAGACCCAGTACTTCGGGCCA	CASNRQGAA*GETQYF	Stop	VDJ	1	29	9.879403147782244E-4		48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	0	5	3	10	23	33	46	36	56		TCRBV06-04,TCRBV06-08												CASNRQGAA*GETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCACAACAGGGGGCTCGTGGACTGAAGCTTTCTTTGGACAA	CASSTTGGSWTEAFF	In	VDJ	1	30	0.0010220072221843702	0.0014001026741961077	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	5	3	6	18	30	42	33	48		TCRBV11-01,TCRBV11-03												CASSTTGGSWTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATCGGGGGGGTCCTGAAAAACTGTTTTTTGGCAGT	CASSYRGGPEKLFF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	0	7	1	3	26	40	49	41	52		TCRBV06-07,TCRBV06-08												CASSYRGGPEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGTTCTCCGGGACGTCGGGGGAAAAACTGTTTTTTGGCAGT	CASRFSGTSGEKLFF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	6	0	7	8	7	7	23	34	46	41	53		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFSGTSGEKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCAGGGTACCTACGAGCAGTACTTCGGGCCG	CASSYQGTYEQYF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	2	0	2	23	-1	43	38	45		TCRBV06-07,TCRBV06-08												CASSYQGTYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TTCTGTGCCAGCAGTTACACCATAACCAGGTTGGGGTAATGCAAGAAAATGAACACTGAAGCTTTCTTTGGACAA	CASSYTITRLG*CKKMNTEAFF	Stop	VDJ	1	42	0.0014308101110581182		66	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	2	4	4	0	8	19	3	18	30	26	49		TCRBV06-02,TCRBV06-03,TCRBV06-05,TCRBV06-06,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTITRLG*CKKMNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCTGTGTACTTSTGTGCCAGCAGTTACTCGTTTTTTAAAACAGGGGCGCGTCTTCTAAATGAAAAACTGTTTTTTGGCAGT	CASSYSFFKTGARLLNEKLFF	In	VDJ	1	50	0.0017033453703072835	0.002333504456993513	63	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	2	5	10	11	10	27	44	37	55		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYSFFKTGARLLNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGAGAACAGGGACGAACACTGAAGCTTTCTTTGGACAA	CASRRTGTNTEAFF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	4	2	23	34	44	38	46													Vb 22	CASRRTGTNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCCATACCTATGGACAGGGGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	42	0.0014308101110581182		50	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	8	9	1	26	43	61	52	62														X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTCCGGGACCCAGAGACATTCAGTACTTCGGCGCC		Out	VDJ	1	64	0.0021802820739933227		40	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-04	01	4	0	7	8	2	6	26	39	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01		TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGAAAGGGACAGGGGAACTACGAGCAGTACTTCGGGCCG	CASRKGQGNYEQYF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	3	3	2	19	30	43	33	45														CASRKGQGNYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCGATCGGGACAGCAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPIGTATTNEKLFF	In	VDJ	1	44	0.0014989439258704094	0.0020534839221542913	51	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	0	5	3	29	42	54	47	57			01,02											CASSPIGTATTNEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCTGGGGGTCGAGCAGTACTTCGGGCCG	CSARDLGVEQYF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	6	1	6	3	1	26	40	48	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCAGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CSARDPGTSTDTQYF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	0	4	0	26	40	-1	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPGTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGGGGACAGGGGGCTTTTATTCACCCCTCCACTTTGGGAAC	CSASEGTGGFYSPLHF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	0	8	4	4	26	37	53	41	57		TCRBV20-01,TCRBV20-or09_02												CSASEGTGGFYSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGGGATAACACAGATACGCAGTATTTTGGCCCA	CSVGDNTDTQYF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	7	0	8	2	3	3	26	33	40	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVGDNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCACAGGGGGAGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	6.132043333106221E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	1	4	0	4	18	-1	43	35	47	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCGGGGCATTGCCGAGCAGTACTTCGGGCCG	CASSFRGIAEQYF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	7	0	6	2	5	26	40	47	42	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRGIAEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGATGGACAGGGGGATTCACTGAAGCTTTCTTTGGACAA	CSARWTGGFTEAFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	4	1	3	26	38	49	39	52		TCRBV20-01,TCRBV20-or09_02												CSARWTGGFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCGCGAGCGACGGGGAGCTGTTTTTTGGAGAA	CATSASDGELFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	6	6	7	4	1	24	35	43	39	44		TCRBV24-01,TCRBV24-or09_02				01,02								CATSASDGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTGGACAGGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	6.472712407167677E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	0	2	4	24	38	48	40	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGTCGGAGCGGGGCGACTCCTACGAGCAGTACTTCGGGCCG	CASRSERGDSYEQYF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	6	3	0	5	3	24	35	47	40	50		TCRBV24-01,TCRBV24-or09_02												CASRSERGDSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTGGTTGCTGGGACAGGGTAATTAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	6.472712407167677E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	9	7	5	18	32	48	39	53	TCRBV05,TCRBV07													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTGGGGGGTCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	6.813381481229134E-4		41	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	1	0	3	2	26	37	46	40	48	TCRBV12,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCGCACCCCGACTCTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSRTPTLAKNIQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	2	10	1	8	3	26	38	50	46	53		TCRBV12-03,TCRBV12-04				01,02								CASSRTPTLAKNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD02-01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGGGGACCGAGCAGTACTTCGGGCCG	CSARLGTEQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	33	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	0	7	6	3	0	26	38	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLGTEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCCTCCTCTAGCGGGGGCCACGAGCAGTACTTCGGGCCG	CASSSSSSGGHEQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	5	6	2	18	31	47	37	49	TCRBV07,TCRBV11													CASSSSSSGGHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGGCCGACTAGTAAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASRPTSKSYNEQFF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	8	1	3	4	23	34	43	37	47	TCRBV06,TCRBV10					01,02								CASRPTSKSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCAGCAGTGACACGCCCCCTGGACCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	6.813381481229134E-4		41	unresolved						TCRBJ02	TCRBJ02-01	01	3	1	7	10	10	1	23	37	51	47	52	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGGGACAGGGGTTCGACGAGCAGTACTTCGGGCCG	CASSLGQGFDEQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	5	0	4	19	-1	43	35	47		TCRBV05-06,TCRBV05-07												CASSLGQGFDEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTAGAAACAGGGAACACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	7.154050555290591E-4		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	5	4	3	26	39	49	43	52		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTTTGGGTCATACAGAACTATGGCTACACCTTCGGTTCG	XASSFWVIQNYGYTF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	5	2	10	0	27	40	-1	50	54	TCRBV26,TCRBV28													XASSFWVIQNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTTAAGGTTCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA	CASSL*GSISIRTEAFF	Stop	VDJ	1	21	7.154050555290591E-4		51	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	4	4	4	15	26	39	46	43	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSL*GSISIRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGGGCTGAAGGCTACACCTTCGGTTCG	CSARQGAEGYTF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	8	0	4	26	-1	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSARQGAEGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCGCAGGGTGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPAGWDSNQPQHF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	0	5	5	22	33	43	38	48		TCRBV12-03,TCRBV12-04												CASSPAGWDSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTTCTAGCGGGGGATCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	7.154050555290591E-4		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	5	4	3	24	38	52	42	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGAACAGGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	7.154050555290591E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	4	3	1	24	39	48	42	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGACTATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLDYYSNQPQHF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	45				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	3	9	0	0	3	18	-1	38	34	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02				01,02								CASSLDYYSNQPQHF+X+TCRBJ01-05		TCRBD02-01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGRSWCKSSKSYSTWTMTCTKTGCCAGCAGCTTCTTCTAGCGGGGGAGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	21	7.154050555290591E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	13	4	2	5	12	2	19	22	44	34	46	TCRBV05,TCRBV07													X+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCGGGCAGGGGACAGCCCCAGCATTTTGGTGAT	CASSQDSGRGQPQHF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	7	6	1	26	43	55	49	56		TCRBV03-01,TCRBV03-02												CASSQDSGRGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGAAGCCGGGGAGCTGTTTTTTGGAGAA	CSARDREAGELFF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	6	0	3	26	-1	45	40	48		TCRBV20-01,TCRBV20-or09_02												CSARDREAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCCGGGGCCCCGGAGACCCAGTACTTCGGGCCA	CSAPPGAPETQYF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	7	0	5	6	4	26	35	46	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPPGAPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGATCGGGACTAGCGGGGGGTGAGGCCCAGTACTTCGGGCCA	CASRSGLAGGEAQYF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	9	3	5	18	29	47	32	52	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CASRSGLAGGEAQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAACGGAGAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLTERSSYEQYF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	0	2	5	22	37	43	39	48	TCRBV07,TCRBV11													CASSLTERSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGATCAAGACGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGSRRENTGELFF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	3	1	8	0	23	36	-1	44	49	TCRBV09,TCRBV12													CASSGSRRENTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTCAACTACTAAGGGTCTGAGCAATCAGCCCCAGCATTTTGGTGAT	XASSSTTKGLSNQPQHF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	51	unresolved						TCRBJ01	TCRBJ01-05	01	4	5	3	1	9	4	25	38	51	47	55	TCRBV26,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSSTTKGLSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACAGGAGGACAGGGTTCTTGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	7.835388703413504E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	3	3	4	7	24	32	44	36	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCGGAGACTTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	8.176057777474961E-4		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	10	3	6	2	26	39	49	45	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATAGATAGTGGTGTCGGCGAGCAGTACTTCGGGCCG	CSASIDSGVGEQYF	In	VDJ	1	24	8.176057777474961E-4	0.0011200821393568862	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	8	6	2	13	26	37	42	39	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASIDSGVGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCGGGGCACCGACTCGCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	8.176057777474961E-4		55	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	7	0	0	4	12	24	36	45	40	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTGGGGTCCGGAGAGACCCAGTACTTCGGGCCA	CASSPLGSGETQYF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	6	2	4	4	5	26	39	47	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGSGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGGGATTCACCCCTCCACTTTGGGAAC	CASSRGDSPLHF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	1	8	0	0	26	-1	-1	39	45		TCRBV03-01,TCRBV03-02												CASSRGDSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTGGATCATCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	8.516726851536418E-4		43	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	1	8	5	2	12	26	38	43	40	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGACGGTCTTTAATCAGCCCCAGCATTTTGGTGAT	CSARDSTVFNQPQHF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	2	7	4	3	7	26	40	46	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSTVFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATATCGCAGGGGAGTTACGAGCAGTACTTCGGGCCG	CASSLISQGSYEQYF	In	VDJ	1	25	8.516726851536418E-4	0.0011667522284967565	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	4	6	3	18	33	45	39	48	TCRBV07,TCRBV11													CASSLISQGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGGGCTGACAGGTTATTTGGAACACCATATATTTTGGAGAG		Out	VDJ	1	26	8.857395925597874E-4		46	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	4	7	5	8	26	38	49	43	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCGGACAGGCAATGAGCAGTTCTTCGGGCCA	CSALRTGNEQFF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	6	4	0	26	35	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSALRTGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTGTCCGGACAGGGGGCATACGAGCAGTACTTCGGGCCG	CASSELSGQGAYEQYF	In	VDJ	1	26	8.857395925597874E-4	0.0012134223176366267	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	0	4	6	1	23	38	55	44	56		TCRBV06-01,TCRBV06-08												CASSELSGQGAYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGAAGGACTAGCGGGTATCACTACGAGCAGTACTTCGGGCCG	CSARRTSGYHYEQYF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	4	3	1	5	26	38	50	39	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRTSGYHYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAGCCCCTTATACTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	9.198064999659331E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	10	0	8	2	23	34	45	42	47	TCRBV25,TCRBV28					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGTTGGGCTGGGGACAGATACGCAGTATTTTGGCCCA	CASSLVGLGTDTQYF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	6	2	3	9	0	18	32	-1	41	45	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGLGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCAGGMGACWCRGCWSKGTATYTCTGTGCCAGCAGCCTTAGCGGGTTTAACACAGATACGCAGTATTTTGGCCCA	CASSLSGFNTDTQYF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	2	2	5	24	36	45	38	50	TCRBV07,TCRBV21					01,02								CASSLSGFNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGTTCCCTAGGGCCCCAGCATTTTGGTGAT	CASSQAGSLGPQHF	In	VDJ	1	28	9.538734073720787E-4	0.0013067624959163672	42	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	4	4	9	0	9	26	-1	46	42	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGSLGPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTGCCCGGGACAGGGGAAGAGACCCAGTACTTCGGGCCA	CSARLPGTGEETQYF	In	VDJ	1	28	9.538734073720787E-4	0.0013067624959163672	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	2	3	6	0	26	38	-1	44	54		TCRBV20-01,TCRBV20-or09_02												CSARLPGTGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTAACAGGGCTTCGCTACGAGCAGTACTTCGGGCCG	CASSLTGLRYEQYF	In	VDJ	1	28	9.538734073720787E-4	0.0013067624959163672	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	3	3	4	5	23	34	44	38	49	TCRBV02,TCRBV13	TCRBV02-01,TCRBV13-01												CASSLTGLRYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGAAGGGACTAGCGCGGAGACCCAGTACTTCGGGCCA	CASSVEGTSAETQYF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	6	5	7	2	26	37	54	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSVEGTSAETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACTGGGGGGACGGGAGCAGTTCTTCGGGCCA	CASSQLGGREQFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	1	10	2	4	26	41	49	43	53		TCRBV03-01,TCRBV03-02												CASSQLGGREQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTAGTAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSSRATDTQYF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	39	unresolved						TCRBJ02	TCRBJ02-03	01	5	5	3	2	3	1	23	35	42	38	43	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRATDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCAGGCAATTGGCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	30	0.0010220072221843702		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	5	18	30	46	42	51	TCRBV07,TCRBV11													X+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGTCTCGGACACAACCTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	0.0010560741295905158		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	6	1	7	6	26	42	54	49	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGGGCCAGGGGGCGCGACTGAAGCTTTCTTTGGACAA	CASSVGPGGATEAFF	In	VDJ	1	31	0.0010560741295905158	0.001446772763335978	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	5	8	3	22	33	49	41	52		TCRBV12-03,TCRBV12-04												CASSVGPGGATEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCAAAAATTTAGCAGCCGGGGAGCTGTTTTTTGGAGAA	CASSKNLAAGELFF	In	VDJ	1	31	0.0010560741295905158	0.001446772763335978	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	5	7	6	8	2	24	35	47	43	49	TCRBV24,TCRBV27					01,02								CASSKNLAAGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTTATAGCGGGGACACAGATACGCAGTATTTTGGCCCA	CASYSGDTDTQYF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	5	3	2	4	1	24	31	43	35	44	TCRBV06,TCRBV10													CASYSGDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGTCGGTCGAACAGAGCGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSQDWSVEQSGGNEQFF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	57	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	7	16	1	24	41	65	57	66		TCRBV03-01,TCRBV03-02												CASSQDWSVEQSGGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TCCTCAGTGACTCKGSCKTSTATSTCTGTGCCAGCAGCTTAGACAGAGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLDRESSYNEQFF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	48	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	8	2	5	0	9	6	26	32	46	41	52	TCRBV11,TCRBV30			TCRBD01,TCRBD02										CASSLDRESSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTATTATTGAAGCTTTCTTTGGACAA	CASSQGIIEAFF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	9	7	1	4	26	42	45	43	49		TCRBV03-01,TCRBV03-02				01,02								CASSQGIIEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATAACGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CSAYNGLSYEQYF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	9	0	0	6	2	26	35	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAYNGLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCATCCAGCGGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASIQRGGTGELFF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	6	0	4	3	0	23	33	-1	36	46	TCRBV02,TCRBV09													CASIQRGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTATCGTGGGCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	35	0.0011923417592150985		41	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	8	0	5	6	2	26	40	50	46	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTACAGTTTCTTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	35	0.0011923417592150985		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	5	5	2	15	26	38	44	40	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCCCCCCTAGCGGTCTCTCCTACGAGCAGTACTTCGGGCCG	CSALPPSGLSYEQYF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	5	0	8	3	26	34	49	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSALPPSGLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATATAGGAAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSQDIGSTGELFF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	45							TCRBJ02	TCRBJ02-02	01	0	1	8	5	4	3	18	35	42	39	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDIGSTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAGAGTGCTCTCTAATGCGGACACTGAAGCTTTCTTTGGACAA	CASSLARVLSNADTEAFF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	54				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	5	3	16	0	18	35	-1	51	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLARVLSNADTEAFF+X+TCRBJ01-01		TCRBD02-01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTTTACAGGGGGCCGTCGGGGAGCTGTTTTTTGGAGAA	CASSFLQGAVGELFF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	0	7	3	3	18	32	44	35	47	TCRBV07,TCRBV11													CASSFLQGAVGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTGACGGACAGGGGGACGGTCGAGCAGTACTTCGGGCCG	CASSLTDRGTVEQYF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	1	6	5	5	19	31	46	36	51	TCRBV07,TCRBV11													CASSLTDRGTVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCCCGACAGGGGGCTCCGTGACCCAGTACTTCGGGCCA	CASSLPTGGSVTQYF	In	VDJ	1	36	0.0012264086666212441	0.0016801232090353294	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	7	6	5	26	37	53	43	58		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLPTGGSVTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTCAGACCCTTGGGGGAAGTCCACAGATACGCAGTATTTTGGCCCA	CASSSDPWGKSTDTQYF	In	VDJ	1	36	0.0012264086666212441	0.0016801232090353294	51	unresolved						TCRBJ02	TCRBJ02-03	01	6	6	1	2	11	5	20	31	47	42	52	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDPWGKSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTAGCGGGGGGCCCTATGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	37	0.0012604755740273897		44	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	1	5	1	6	26	37	49	38	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGACTAGCCTATACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	37	0.0012604755740273897		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	7	2	3	5	26	40	51	43	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCATTGCGGGAGGGGATATACGAGCAGTACTTCGGGCCG	CASSALREGIYEQYF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	0	4	5	4	26	38	52	43	56		TCRBV12-03,TCRBV12-04												CASSALREGIYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATAGGCTGTCCTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASSIGCPVMQDTQYF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	5	4	5	2	15	26	38	43	40	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIGCPVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTATCTCGTCCCTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA	CASSLSRPFHSDNEQFF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	51	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	4	6	5	15	5	26	38	55	53	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRPFHSDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGTGGGACTAGCGGGAGAAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	38	0.0012945424814335355		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	2	3	4	3	26	34	52	38	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGAATAGCGGGGACGTCGAGCAGTACTTCGGGCCG	CSAQNSGDVEQYF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	3	6	5	4	26	35	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSAQNSGDVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTAACGCGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSALTRGNTGELFF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	3	1	5	0	26	35	-1	40	46		TCRBV20-01,TCRBV20-or09_02												CSALTRGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAATGGGGTGACCCAGTACTTCGGGCCA	CASSLNGVTQYF	In	VDJ	1	38	0.0012945424814335355	0.0017734633873150699	36	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	6	2	7	6	1	24	36	46	42	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGVTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	39	0.001328609388839681		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	5	0	0	0	26	-1	-1	38	41		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCTAACACCGACAGTATCCCAAGAGACCCAGTACTTCGGGCCA	CASSLTPTVSQETQYF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	5	1	8	4	24	36	49	44	53	TCRBV06,TCRBV24													CASSLTPTVSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATTCAGGGGGCAACAAGAAACTGTTTTTTGGCAGT	CAISDSGGNKKLFF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	0	11	4	6	23	35	47	39	53	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDSGGNKKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCCGGACTAGCGGGGGGCCTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	39	0.001328609388839681		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	1	3	3	3	24	36	53	39	56	TCRBV09,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
MRGGGACTYRGSCCTRTATYTCTGTGCCAGCAGCTTCGACAATCAAGAGACCCAGTACTTCGGGCCA	CASSFDNQETQYF	In	VDJ	1	40	0.0013626762962458269	0.0018668035655948103	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	6	2	1	2	22	36	41	37	43	TCRBV05,TCRBV12													CASSFDNQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTCTACGGGGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSSTGAGEKLFF	In	VDJ	1	40	0.0013626762962458269	0.0018668035655948103	42	unresolved						TCRBJ01	TCRBJ01-04	01	4	6	0	7	4	3	23	36	46	40	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTGAGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGACTAGCGGGGGGGCCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	40	0.0013626762962458269		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	0	0	0	4	25	-1	56	41	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGCGATTGAGACCCAGTACTTCGGGCCA	CASSQGAIETQYF	In	VDJ	1	41	0.0013967432036519724	0.0019134736547346805	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	6	5	1	3	26	42	47	43	50		TCRBV03-01,TCRBV03-02				01,02								CASSQGAIETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCTCTCAATAATTCACCCCTCCACTTTGGGAAC	CSARGALNNSPLHF	In	VDJ	1	42	0.0014308101110581182	0.0019601437438745506	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	8	0	5	0	5	26	-1	43	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGALNNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTTACAGGGACCTCCTGAACTATGGCTACACCTTCGGTTCG	CASSSYRDLLNYGYTF	In	VDJ	1	42	0.0014308101110581182	0.0019601437438745506	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	2	4	8	24	36	46	40	54		TCRBV24-01,TCRBV24-or09_02												CASSSYRDLLNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTTCTAGCACTAGCAGATCAGATACGCAGTATTTTGGCCCA	CASSLASSTSRSDTQYF	In	VDJ	1	43	0.0014648770184642638	0.002006813833014421	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	7	4	7	4	18	35	48	42	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLASSTSRSDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGATTCAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSLAIQGWNTEAFF	In	VDJ	1	44	0.0014989439258704094	0.0020534839221542913	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	1	4	2	18	35	45	39	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAIQGWNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGAACTTCCATGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	0.0015330108332765552		44	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	10	5	5	8	26	38	46	43	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCGCCGTTCCCCCCTCTGAAGCTTTCTTTGGACAA	CASSQFAVPPSEAFF	In	VDJ	1	46	0.0015670777406827008	0.0021468241004340316	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	2	10	0	6	3	11	26	41	46	44	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQFAVPPSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCACCAGGGAGGGATGAAGCTTTCTTTGGACAA	CASSQDSPGRDEAFF	In	VDJ	1	46	0.0015670777406827008	0.0021468241004340316	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	0	7	7	1	23	40	54	47	55	TCRBV01,TCRBV04													CASSQDSPGRDEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTAGTGTTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	0.0016011446480888466		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	2	18	26	38	43	40	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACCCGTCGATCGAGGAAACACCATATATTTTGGAGAG	CSAREPVDRGNTIYF	In	VDJ	1	48	0.0016352115554949921	0.0022401642787137723	45	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	2	8	4	7	4	26	40	49	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREPVDRGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTCCGGACAGGGGGAATGGCTACACCTTCGGTTCG	CAISPDRGNGYTF	In	VDJ	1	48	0.0016352115554949921	0.0022401642787137723	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	1	6	2	1	23	35	47	37	48	TCRBV06,TCRBV10													CAISPDRGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSHTGELFF	In	VJ	1	49	0.0016692784629011377	0.0022868343678536427	33	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	0	0	3	0	0	26	-1	-1	-1	39		TCRBV03-01,TCRBV03-02												CASSHTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCATCCCTACGGGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	50	0.0017033453703072835		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	2	10	10	0	26	38	-1	48	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGCGTCGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLWASSTNEKLFF	In	VDJ	1	50	0.0017033453703072835	0.002333504456993513	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	8	0	0	4	5	24	36	44	40	49		TCRBV24-01,TCRBV24-or09_02												CASSLWASSTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTACCGGGACGGCACCAATCAGCCCCAGCATTTTGGTGAT	CSARDYRDGTNQPQHF	In	VDJ	1	51	0.001737412277713429	0.002380174546133383	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	7	3	5	5	26	40	50	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDYRDGTNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCGGGGGTCGTCACAGTACTGATTATGGCTACACCTTCGGTTCG	CGGRHSTDYGYTF	In	VDJ	1	51	0.001737412277713429	0.002380174546133383	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	11	6	1	5	0	16	26	-1	34	29	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CGGRHSTDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCCATGGGTTGGATCTGAAGAGACCCAGTACTTCGGGCCA	CSATPWVGSEETQYF	In	VDJ	1	52	0.001771479185119575	0.0024268446352732533	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	0	9	3	6	9	26	36	45	42	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPWVGSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGGCAAGGGCTGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CATSDGQGLGGANVLTF	In	VDJ	1	52	0.001771479185119575	0.0024268446352732533	51	TCRBV24						TCRBJ02	TCRBJ02-06	01	3	0	8	4	11	0	24	39	-1	50	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDGQGLGGANVLTF+TCRBV24-X+TCRBJ02-06	TCRBV24		TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACCTGACAGAGCTAAGAGAGATTGAAGCTTTCTTTGGACAA	CSARDLTELREIEAFF	In	VDJ	1	53	0.0018055460925257205	0.0024735147244131237	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	5	7	6	13	26	37	48	43	61		TCRBV20-01,TCRBV20-or09_02												CSARDLTELREIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTGGGGAAGGAGGGGCAAGCACTGAAGCTTTCTTTGGACAA	CASSFGEGGASTEAFF	In	VDJ	1	56	0.0019077468147441574	0.0026135249918327343	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	4	7	5	18	32	45	39	50	TCRBV07,TCRBV11													CASSFGEGGASTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGGACACTGAAGCTTTCTTTGGACAA	CASSFGDTEAFF	In	VDJ	1	57	0.0019418137221503032	0.0026601950809726047	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	6	2	3	1	0	26	40	-1	41	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTAGATCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSRRSGGELFF	In	VDJ	1	57	0.0019418137221503032	0.0026601950809726047	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	7	6	0	26	39	-1	45	49		TCRBV03-01,TCRBV03-02				01,02								CASSRRSGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAATAGCGGGGGGGTACGAGCAGTACTTCGGGCCG	CASSQEIAGGYEQYF	In	VDJ	1	57	0.0019418137221503032	0.0026601950809726047	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	0	4	2	0	23	40	-1	42	53	TCRBV01,TCRBV04													CASSQEIAGGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACAGCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQEQRNTGELFF	In	VDJ	1	58	0.001975880629556449	0.002706865170112475	45	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	3	5	1	0	2	26	-1	47	43	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEQRNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTGAAGGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSEFEGGSYEQYF	In	VDJ	1	59	0.0020099475369625944	0.0027535352592523454	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	1	6	0	23	38	-1	44	50		TCRBV06-01,TCRBV06-08												CASSEFEGGSYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAAATGGGCGGGGGAGGCAGGTCGGGATACGCAGTATTTTGGCCCA	CSAKWAGEAGRDTQYF	In	VDJ	1	62	0.0021121482591810316	0.002893545526671956	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	2	6	7	11	26	34	48	41	59		TCRBV20-01,TCRBV20-or09_02												CSAKWAGEAGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATACACCGGGACAGGGATCTGATGAGCAGTTCTTCGGGCCA	CSAYTPGQGSDEQFF	In	VDJ	1	62	0.0021121482591810316	0.002893545526671956	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	8	5	26	35	52	43	57		TCRBV20-01,TCRBV20-or09_02												CSAYTPGQGSDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGCTAACTTTACAGGGAGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	63	0.002146215166587177		53	TCRBV20						TCRBJ02	TCRBJ02-02	01	3	3	3	2	11	4	26	37	54	48	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAAGGGGATCCAATCAGCCCCAGCATTTTGGTGAT	CSATRGSNQPQHF	In	VDJ	1	64	0.0021802820739933227	0.0029868857049516963	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	3	2	3	26	36	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSATRGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTACTCGACAGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSYSTGGQPQHF	In	VDJ	1	65	0.0022143489813994687	0.0030335557940915667	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	4	7	0	4	23	-1	46	40	50	TCRBV06,TCRBV10													CASSYSTGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGCAATGTCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	66	0.0022484158888056143		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	6	5	14	5	26	39	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACTTCGTTGGGGCACGATACGCAGTATTTTGGCCCA	CASTSLGHDTQYF	In	VDJ	1	67	0.00228248279621176	0.0031268959723713074	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	6	7	2	26	36	48	43	50		TCRBV03-01,TCRBV03-02												CASTSLGHDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGATATAGGAAAGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSQDIGKGNEKLFF	In	VDJ	1	67	0.00228248279621176	0.0031268959723713074	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	5	8	0	18	35	-1	43	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDIGKGNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACGCGGCCCTGCCCGTGGAAACACCATATATTTTGGAGAG	CASRRGPARGNTIYF	In	VDJ	1	68	0.0023165497036179055	0.0031735660615111773	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	7	5	3	2	9	26	37	43	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRRGPARGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCARCCAGACCTMTCTGTACYWCTGTGCCAGCAGTTTGAGGGGGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLRGDSYNEQFF	In	VDJ	1	68	0.0023165497036179055	0.0031735660615111773	45	unresolved						TCRBJ02	TCRBJ02-01	01	3	5	1	0	1	2	23	37	44	38	46	TCRBV08,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGDSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAAGACAGGGGAGCTTTCTTTGGACAA	CASSQQDRGAFF	In	VDJ	1	70	0.002384683518430197	0.003266906239790918	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	2	10	3	0	26	41	-1	44	52		TCRBV03-01,TCRBV03-02												CASSQQDRGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATACACTAGCGGGGAAACACCGGGAAGCTGTTTTTTGGAGAA	CAIH*RGNTGKLFF	Stop	VDJ	1	71	0.0024187504258363426		42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	11	3	3	12	3	11	24	31	44	34	55		TCRBV24-01,TCRBV24-or09_02												CAIH*RGNTGKLFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGTCGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CSARDMSGLAKNIQYF	In	VDJ	1	78	0.002657218777679362	0.00364026695290988	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	10	0	6	0	26	40	-1	46	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDMSGLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCCGGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	80	0.0027253525924916537		43	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	8	3	1	3	0	26	40	-1	43	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTCCCGGGCCTCAAGAGACCCAGTACTTCGGGCCA	CASSFPGPQETQYF	In	VDJ	1	80	0.0027253525924916537	0.0037336071311896207	42	unresolved						TCRBJ02	TCRBJ02-05	01	2	8	0	2	4	2	19	33	41	37	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFPGPQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTAGGAGGCAGAAACTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLALGGRNFQETQYF	In	VDJ	1	80	0.0027253525924916537	0.0037336071311896207	54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	1	4	9	18	35	44	39	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALGGRNFQETQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ARRRRGACTCAGCYGYGTATCTCTRCACCAGCAGCCAAGAGGAGGGGGGGAAGAACGAGCAGTACTTCGGGCCG	XTSSQEEGGKNEQYF	In	VDJ	1	80	0.0027253525924916537	0.0037336071311896207	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	9	0	5	16	4	22	26	49	42	53	TCRBV01,TCRBV17													XTSSQEEGGKNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCCCCGAGGTGCAGGGGGATTGGGGCGAGCAGTACTTCGGGCCG	CASSPEVQGDWGEQYF	In	VDJ	1	81	0.0027594194998977993	0.0037802772203294906	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	6	9	7	18	30	46	39	53	TCRBV05,TCRBV11													CASSPEVQGDWGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTGGACAGGGATGGACACTGAAGCTTTCTTTGGACAA	CSAWTGMDTEAFF	In	VDJ	1	82	0.002793486407303945	0.003826947309469361	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	3	2	4	26	34	44	36	48		TCRBV20-01,TCRBV20-or09_02												CSAWTGMDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCTCCGCGAGGGGCCTGGGGGGAATGAGCAGTTCTTCGGGCCA	XASSLREGPGGNEQFF	In	VDJ	1	84	0.0028616202221162365	0.003920287487749101	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	1	7	14	0	23	36	-1	50	56	TCRBV04,TCRBV07,TCRBV17													XASSLREGPGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCGGTAGTCCGCACAGATACGCAGTATTTTGGCCCA	CASSLSVVRTDTQYF	In	VDJ	1	88	0.002997887851740819	0.004106967844308583	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	8	1	4	3	26	41	48	45	51		TCRBV12-03,TCRBV12-04				01,02								CASSLSVVRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCCGGGACAGGGGGCGTAGCACTGAAGCTTTCTTTGGACAA	CSAFRDRGRSTEAFF	In	VDJ	1	88	0.002997887851740819	0.004106967844308583	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	0	4	4	4	26	35	51	39	55		TCRBV20-01,TCRBV20-or09_02												CSAFRDRGRSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCTCGGGACTAGCGGGGGTGAGCTGGCCCAGTACTTCGGGCCA		Out	VDJ	2	104	0.00354295837023915		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	9	4	8	23	35	53	39	61	TCRBV09,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGAGAGAATTTCTCTGAGACCCAGTACTTCGGGCCA	CASSGENFSETQYF	In	VDJ	2	114	0.0038836274443006065	0.005320390161945209	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	2	5	0	11	26	-1	42	38	53		TCRBV03-01,TCRBV03-02												CASSGENFSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACCACGGGACTAGCGACTCAAGAGACCCAGTACTTCGGGCCA	CSATTGLATQETQYF	In	VDJ	2	119	0.004053961981331335	0.00555374060764456	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	6	2	6	3	26	34	50	40	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSATTGLATQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTCCGGGGGGCCCACCTACGAGCAGTACTTCGGGCCG	CSAPSGGPTYEQYF	In	VDJ	2	146	0.004973768481297268	0.006813833014421057	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	2	5	4	26	35	47	40	51		TCRBV20-01,TCRBV20-or09_02												CSAPSGGPTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCGGAGGGAGACCCCCGGAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	2	153	0.005212236833140287		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	5	3	13	26	39	48	42	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCTGGGGCGGAGGGGACCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	178	0.00606390951829393		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	0	6	9	3	24	35	50	44	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATTACGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CSAITGASTDTQYF	In	VDJ	15	983	0.033487769980241194	0.045876697624492466	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	6	0	0	6	1	26	34	46	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAITGASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CSAIAGGSTDTQYF	In	VDJ	16	1038	0.03536144988757921	0.048443552527185324	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	0	0	0	26	-1	-1	36	47		TCRBV20-01,TCRBV20-or09_02												CSAIAGGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATATGTCCCCAGGGCGGAATCAGCCCCAGCATTTTGGTGAT	CASSQDMSPGRNQPQHF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	8	3	23	40	53	48	56													Vb 7.1	CASSQDMSPGRNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAAACCCGGGGGCCGGAGTACTTCGGGCCA	YASSQETRGPEYF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	0	6	0	12	5	3	22	39	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQETRGPEYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCTTGGCGGCGACAACACAGATACGCAGTATTTTGGCCCA	CASSLGGDNTDTQYF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	6	2	6	2	10	1	23	34	48	44	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSLGGDNTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGGCTCAGCCTATCAGCCCCAGCATTTTGGTGAT	CASSQDGSAYQPQHF	In	VDJ	1	36	0.0012264086666212441	0.0016801232090353294	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	0	4	5	5	5	3	23	40	48	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDGSAYQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCATTACAGGGGGGAGATACGCAGTATTTTGGCCCA	CASSPLQGGDTQYF	In	VDJ	1	40	0.0013626762962458269	0.0018668035655948103	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	1	5	4	1	23	36	48	40	49													Vb 7.1	CASSPLQGGDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAATCCGACAGGGGGTAATCTGGAAACACCATATATTTTGGAGAG	CASSQESDRG*SGNTIYF	Stop	VDJ	2	130	0.0044286979627989375		54	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	1	1	4	3	23	40	53	44	56													Vb 7.1	CASSQESDRG*SGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGATGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	6.813381481229134E-4		34	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	3	10	0	2	1	0	26	40	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTCTGGGCTACTTTATGGCTACACCTTCGGTTCG	CATSRDSGLLYGYTF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	8	0	5	4	5	18	35	43	39	48														CATSRDSGLLYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTAGAGGCCGACGGCAATGAGCAGTTCTTCGGGCCA	CASSLEADGNEQFF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	11	1	6	3	7	18	30	37	33	44														CASSLEADGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGGGACCAGATACGCAGTATTTTGGCCCA	CATSRDQGPDTQYF	In	VDJ	1	42	0.0014308101110581182	0.0019601437438745506	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	0	0	7	4	3	0	18	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDQGPDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGCCCGTTTTAAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	59	0.0020099475369625944		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	7	4	0	10	18	-1	39	35	49						01,02								X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACTAGCGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CATSTSGGATDTQYF	In	VDJ	1	68	0.0023165497036179055	0.0031735660615111773	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	0	1	18	-1	43	31	44														CATSTSGGATDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCCCTCGGGGTGACTCCTACAATGAGCAGTTCTTCGGGCCA	CATSSPRGDSYNEQFF	In	VDJ	1	80	0.0027253525924916537	0.0037336071311896207	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	3	0	4	3	18	32	41	36	44														CATSSPRGDSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGCGACAGGGCGGTGGGAGACCCAGTACTTCGGGCCA	CATSATGRWETQYF	In	VDJ	2	102	0.003474824555426858	0.004760349092266766	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	5	2	6	18	30	39	32	45														CATSATGRWETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCCGGGACAGGGCACCGAGCAGTACTTCGGGCCG	CASSQPGQGTEQYF	In	VDJ	1	21	7.154050555290591E-4	9.800718719372753E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	5	3	18	30	44	35	47														CASSQPGQGTEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGCTTTACGGGGACGGAGACCCAGTACTTCGGGCCA	CASSLSFTGTETQYF	In	VDJ	1	22	7.494719629352047E-4	0.0010267419610771457	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	0	7	5	10	1	18	32	47	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSFTGTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTGGATGACAGGGGTGGGGGATCAGCCCCAGCATTTTGGTGAT	CASSSWMTGVGDQPQHF	In	VDJ	1	24	8.176057777474961E-4	0.0011200821393568862	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	2	5	7	6	18	31	46	38	52														CASSSWMTGVGDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	8.857395925597874E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	3	0	0	18	-1	-1	35	41														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGACGCAGTGGYAGGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	8.857395925597874E-4		55	TCRBV11	TCRBV11-03	01	unresolved			TCRBJ01	TCRBJ01-02	01	6	2	7	4	0	25	18	-1	32	29	57				TCRBD01,TCRBD02										X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	unresolved	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGTTCGGACGGAGATTAGAAGCTTTCTTTGGACAA	CASSLSFGRRLEAFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	1	7	8	6	8	18	33	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSFGRRLEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGTTCATTAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	32	0.0010901410369966614		56	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	18	30	49	46	54														X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTCTACAGGGGGCGAATAATTCACCCCTCCACTTTGGGAAC	CASSLLQGANNSPLHF	In	VDJ	1	32	0.0010901410369966614	0.0014934428524758481	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	0	5	5	2	18	30	44	35	46														CASSLLQGANNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTCGATAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFDSGGTDTQYF	In	VDJ	1	33	0.0011242079444028072	0.0015401129416157185	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	1	6	0	18	29	-1	35	43														CASSFDSGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGCGGGGATCGGCGGCAAGATACGCAGTATTTTGGCCCA	CASSLGTSGDRRQDTQYF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	5	0	10	18	-1	46	34	56														CASSLGTSGDRRQDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGTGCCCTCAATGAGCAGTTCTTCGGGCCA	CASSLGGALNEQFF	In	VDJ	1	77	0.0026231518702732166	0.0035935968637700096	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	1	6	2	6	0	6	18	-1	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGALNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGACACCACAGATACGCAGTATTTTGGCCCA	CASSLGDTTDTQYF	In	VDJ	3	171	0.005825441166450909	0.007980585242917814	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	6	2	0	1	18	-1	40	34	41														CASSLGDTTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTACGGGTCTATGAACACTGAAGCTTTCTTTGGACAA	CASSFYGSMNTEAFF	In	VDJ	3	219	0.007460652721945901	0.010220749521631586	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	0	3	4	18	32	39	35	43						01,02								CASSFYGSMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACTACGGGGCAGGGGCCCAGTACTTCGGGCCA	CASSLYYGAGAQYF	In	VDJ	6	353	0.012025618314369421	0.016474541466374202	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	9	10	0	18	33	-1	43	49														CASSLYYGAGAQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGGTGACGCCGGGGAGCTGTTTTTTGGAGAA	CASSLRGDAGELFF	In	VDJ	7	449	0.015296041425359405	0.020954870023801746	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	8	3	6	0	5	18	-1	38	33	43														CASSLRGDAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGACTATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDYYSNQPQHF	In	VDJ	23	1478	0.0503508891462833	0.06897839174872825	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	1	9	0	2	3	18	30	38	32	41						01,02								CASSQDYYSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCTGCAAAGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	7.154050555290591E-4		38	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	2	5	6	0	26	38	-1	44	49														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCATCTGCTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	7.494719629352047E-4		40	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	12	4	5	0	0	9	26	-1	34	31	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTGAAAGCCCGACGCGTATCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	9.879403147782244E-4		52	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	0	2	7	4	8	8	26	43	54	51	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCGTTGACGGGGGTGGGACGGTCTATATGGCTACACCTTCGGTTCG		Out	VDJ	1	87	0.002963820944334673		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	2	5	6	12	26	39	51	45	63														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTGSGANVLTF	In	VDJ	2	148	0.005041902296109559	0.006907173192700798	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	12	8	4	1	6	0	26	31	-1	37	41						01,02								CASTGSGANVLTF+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD02-01	TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCGGGACAGGGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	7	447	0.015227907610547115		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	2	3	2	26	38	51	41	53														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACGGGACAGGGGGCCTCCAGTTCTTCGGGCCA	CASSHGTGGLQFF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	0	13	4	3	20	31	47	35	50														CASSHGTGGLQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGGACAGGGATGACACTGAAGCTTTCTTTGGACAA	CASRDRDDTEAFF	In	VDJ	1	46	0.0015670777406827008	0.0021468241004340316	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	3	0	3	20	-1	39	31	42														CASRDRDDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCCGGACAGTACACTGAAGCTTTCTTTGGACAA	CASSSGQYTEAFF	In	VDJ	1	49	0.0016692784629011377	0.0022868343678536427	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	3	4	1	20	31	41	35	42														CASSSGQYTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTACCGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CAISTGDSNQPQHF	In	VDJ	1	18	6.132043333106221E-4	8.400616045176647E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	0	2	1	23	35	42	37	43														CAISTGDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGACAGGAGGGCACTGAAGCTTTCTTTGGACAA	CASRRQEGTEAFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	2	4	4	2	4	23	34	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRQEGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTACGGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVRGGSYNEQFF	In	VDJ	1	19	6.472712407167677E-4	8.867316936575349E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	0	3	0	23	35	-1	38	46														CASSVRGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAACGGGGAGACCGAGCTTAAGACTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	6.813381481229134E-4		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	3	4	5	18	23	34	44	39	62						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAATATCAAATGAAAAACTGTTTTTTGGCAGT	CASSYGISNEKLFF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	1	8	5	0	6	23	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGISNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCTCCGCCAGGGACAGCCAACACTGAAGCTTTCTTTGGACAA	CAISPPPGTANTEAFF	In	VDJ	1	20	6.813381481229134E-4	9.334017827974052E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	9	2	23	35	51	44	53														CAISPPPGTANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGTAGCGGGGGCCCACTTGCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	22	7.494719629352047E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	4	6	9	23	35	50	41	59														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCTACGAATACGGGGCAGGCGATTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	7.494719629352047E-4		59	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	7	0	1	12	8	22	37	54	49	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATTTAAGGGGCTAGCTTCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	7.835388703413504E-4		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	2	3	6	9	23	34	45	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGAGGGACTGAAGCTTTCTTTGGACAA	CASSPGGTEAFF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	0	5	3	0	23	35	-1	38	44														CASSPGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCTAGGCCAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSYPLGQGGTDTQYF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	1	9	0	23	38	-1	47	54														CASSYPLGQGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTGGGGGACGGGCGTATGACTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	8.176057777474961E-4		49	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	0	7	4	4	12	23	33	42	37	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTAGTGGCGGGGGCCTCCGTTGGGCCCCACGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	8.857395925597874E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	2	7	6	17	23	36	49	42	66														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAGACAGGGAGGAGGCTTTCTTTGGACAA	CASSTDREEAFF	In	VDJ	1	27	9.198064999659331E-4	0.001260092406776497	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	11	3	5	23	35	45	38	50														CASSTDREEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTCAAAAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPQKNTGELFF	In	VDJ	1	29	9.879403147782244E-4	0.0013534325850562375	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	6	4	6	1	4	3	23	34	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQKNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAAGCGGGGGCGCCTCTGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	29	9.879403147782244E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	2	10	2	8	23	37	47	39	55														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCACCTCAAGAATGAACTCTGGAAACACCATATATTTTGGAGAG	CASSRTSRMNSGNTIYF	In	VDJ	1	31	0.0010560741295905158	0.001446772763335978	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	2	8	0	10	5	23	35	47	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTSRMNSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTCATGACGGGGGCATTGATGAAAAACTGTTTTTTGGCAGT	CATHDGGIDEKLFF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	10	6	0	6	8	4	23	30	44	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATHDGGIDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGAGATGAGAGGGTCCACGAGCAGTACTTCGGGCCG	CASSYSGDERVHEQYF	In	VDJ	1	35	0.0011923417592150985	0.001633453119895459	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	2	5	0	12	23	-1	45	40	57														CASSYSGDERVHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCGGACTAGCGGGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSPGLAGGSTDTQYF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	1	2	4	3	23	34	52	38	55														CASSPGLAGGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGGCTTTGCCGGGCCCAAAGGGACCTGGGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	37	0.0012604755740273897		55	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	9	0	7	2	17	7	23	31	53	48	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACAAGGGAGGAGGGGGAACTGATGGAAGAGACCCAGTACTTCGGGCCA	CASRTREEGELMEETQYF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	5	1	3	11	9	23	34	51	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTREEGELMEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGACAGGGCCGGTAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTGPVTNEKLFF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	1	3	5	23	34	44	37	49														CASSLTGPVTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	0.0014989439258704094		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	2	0	0	23	-1	-1	35	41														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGTTCCCAGTGATGTTTCCATCCAGCCCCAGCATTTTGGTGAT	CASVPSDVSIQPQHF	In	VDJ	1	45	0.0015330108332765552	0.0021001540112941617	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	5	7	5	13	23	32	40	37	53														CASVPSDVSIQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCGCCGAATAGCCGTCCGAGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	48	0.0016352115554949921		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	7	10	10	7	23	35	49	45	56						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTGTGACCAGAGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	49	0.0016692784629011377		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	11	1	8	11	0	23	33	-1	44	48														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCACGTCCTTCCGGGGTTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	0.001771479185119575		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	7	12	1	23	33	50	45	51														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCAGGGCCTACGAGCAGTACTTCGGGCCG	CASSYSGRAYEQYF	In	VDJ	1	52	0.001771479185119575	0.0024268446352732533	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	2	3	0	23	40	-1	43	48														CASSYSGRAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGACTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSDGTSGGNEQFF	In	VDJ	1	54	0.0018396129999318663	0.002520184813552994	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	6	3	0	23	35	-1	38	52														CASSDGTSGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGCGGGGATGAAGCTTTCTTTGGACAA	CASSYSGGDEAFF	In	VDJ	1	55	0.0018736799073380119	0.002566854902692864	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	7	2	1	23	40	48	42	49														CASSYSGGDEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGCGGGCCTAGCCAATGAGCAGTTCTTCGGGCCA	CASSPAGLANEQFF	In	VDJ	1	57	0.0019418137221503032	0.0026601950809726047	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	7	6	9	0	23	35	-1	44	49						01,02								CASSPAGLANEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACAGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSYSQGSGELFF	In	VDJ	1	69	0.002350616611024051	0.0032202361506510476	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	3	6	0	2	23	-1	46	40	48														CASSYSQGSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTGACAGGGAGCATACCTACAATGAGCAGTTCTTCGGGCCA	CASSADREHTYNEQFF	In	VDJ	1	75	0.0025550180554609254	0.0035002566854902693	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	2	3	6	23	35	45	38	51														CASSADREHTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACAGGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSPQGPGELFF	In	VDJ	1	76	0.002589084962867071	0.0035469267746301397	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	2	6	2	1	23	35	44	37	45														CASSPQGPGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTGTTGCCCCGTAGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	79	0.002691285685085508		56	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	23	35	54	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCGAGGGACAGCTACTCTGGAAACACCATATATTTTGGAGAG	CASRPRDSYSGNTIYF	In	VDJ	2	98	0.0033385569258022755	0.004573668735707285	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	5	0	5	3	23	34	46	39	49														CASRPRDSYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASRNRENTEAFF	In	VDJ	2	127	0.0043264972405805	0.005927101320763522	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	2	1	23	34	42	36	43														CASRNRENTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGCTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDGLAGNTGELFF	In	VDJ	4	253	0.008618927573754855	0.011807532552387175	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	4	1	6	0	23	35	-1	41	49						01,02								CASSDGLAGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTACCGGGACGGCCTCTGAAGCTTTCTTTGGACAA	CASSYSTGTASEAFF	In	VDJ	13	802	0.02732165973972883	0.037429411490175944	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	7	6	4	5	23	40	49	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTGTASEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGGATGAGCAGTTCTTCGGGCCA	CASSYSGDEQFF	In	VDJ	14	869	0.029604142535940587	0.04055630746254725	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	8	0	0	23	-1	-1	40	45														CASSYSGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCCGAGATAACTAGCGGGAAAGCCTACGAGCAGTACTTCGGGCCG	CASSPEITSGKAYEQYF	In	VDJ	1	23	7.835388703413504E-4	0.0010734120502170158	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	3	2	10	3	24	35	55	45	58													Vb 18	CASSPEITSGKAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGAACAGGGTCTAACGGCTACACCTTCGGTTCG	CASSPGTGSNGYTF	In	VDJ	1	34	0.0011582748518089527	0.0015867830307555886	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	8	3	6	24	39	48	42	54													Vb 18	CASSPGTGSNGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCGAGGGGCCTAACTCTGGAAACACCATATATTTTGGAGAG	CASSSEGPNSGNTIYF	In	VDJ	1	37	0.0012604755740273897	0.0017267932981751995	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	5	5	2	0	4	5	24	36	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSEGPNSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGGGACAGTGGCTACACCTTCGGTTCG	CASSSGDSGYTF	In	VDJ	1	39	0.001328609388839681	0.00182013347645494	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	7	4	0	24	36	-1	40	47													Vb 18	CASSSGDSGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCTGGGGTCCTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPLLGSSSGANVLTF	In	VDJ	1	49	0.0016692784629011377	0.0022868343678536427	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-06	01	1	6	2	0	4	5	24	40	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLLGSSSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01		TCRBJ02-06*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGACAGGGAAGGCAGATACGCAGTATTTTGGCCCA	CASSQTGKADTQYF	In	VDJ	1	54	0.0018396129999318663	0.002520184813552994	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	3	4	1	4	24	37	45	38	49													Vb 18	CASSQTGKADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATGGGGACCCCGGGCGACAAACCCACTAATTACGAGCAGTACTTCGGGCCG	CASSPMGTPGDKPTNYEQYF	In	VDJ	1	55	0.0018736799073380119	0.002566854902692864	60	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	2	0	7	4	3	22	21	36	44	39	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPMGTPGDKPTNYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGCGACAGGGGTCGACGAGCAGTACTTCGGGCCG	CASSATGVDEQYF	In	VDJ	1	59	0.0020099475369625944	0.0027535352592523454	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	5	3	3	24	35	46	38	49													Vb 18	CASSATGVDEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTGGCAGGGGGCGACCAAACCCAGGGGCAGTACTTCGGGCCG	CASSPVAGGDQTQGQYF	In	VDJ	1	61	0.002078081351774886	0.0028468754375320857	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	0	9	4	14	24	39	51	43	65													Vb 18	CASSPVAGGDQTQGQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGAGGACAGAGGAAAAACTGTTTTTTGGCAGT	CASSPSRTEEKLFF	In	VDJ	1	86	0.0029297540369285276	0.004013627666028842	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	5	8	4	2	24	39	49	43	51													Vb 18	CASSPSRTEEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGACAGGGGAAGGACTGAAGCTTTCTTTGGACAA	CASSRDRGRTEAFF	In	VDJ	1	88	0.002997887851740819	0.004106967844308583	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	5	0	4	24	-1	47	37	51													Vb 18	CASSRDRGRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCAATTTAGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPNLGANTGELFF	In	VDJ	2	110	0.0037473598146760237	0.005133709805385728	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	0	6	0	24	41	-1	47	52													Vb 18	CASSPPNLGANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGACAGGGTACGGACTGAAGCTTTCTTTGGACAA	CASSPDRVRTEAFF	In	VDJ	2	132	0.004496831777611229	0.006160451766462874	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	5	1	5	24	38	46	39	51													Vb 18	CASSPDRVRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1545A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				594	433	153	6	0	378	284	87	7	0	29354	21427	7587	340	0	0.137442961	7.0296216	0.163748533	7.16018772				5041	0.087710686	0.0689783916	0.117667101	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:00	Age (Range):45-65 Years (Late Adulthood),Age:59 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1830,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 653,type of chemo:carbo/taxol	0.7289562090874906	MSKCC- Snyder- P01-02		442.0	
